Rezulin (troglitazone) for Type II diabetes

    The FDA and the HPB are considering Rezulin (troglitazone) for Type II diabetes.

    Troglitazone will be the first drug in a new class.

    It helps reduce insulin underlying metabolic defect in most patients with Type II diabetes.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote